Skp2 inhibitor C1 (SKPin C1)

製品コードS8652 バッチS865201

印刷

化学情報

Synonyms

N/A

Storage
(From the date of receipt)

3 years -20°C powder
1 years -80°C in solvent

化学式

C₁₈H₁₃BrN₂O₄S₂

分子量

465.34

CAS No.

432001-69-9

Solubility (25°C)*

体外

DMSO

93 mg/mL (199.85 mM)

Water

Insoluble

Ethanol

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 Corn oil この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。	1.200mg/ml (2.58mM)	Taking the 1 mL working solution as an example, add 50 μL of 24 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	Skp2 inhibitor C1 (SKPin C1)は、重要な化合物と受容体の接触を介してp27結合を減少させることにより、Skp2を介したp27分解の特異的かつ選択的な小分子阻害剤です。
in vitro	Skp2 inhibitor C1 treatment of MCF-7 breast cancer cells lines does not increase, but rather decrease the percentage of cells in G1 while increasing the G2/M population.

プロトコル(参考用のみ)

細胞アッセイ	細胞株	501 Mel cells
	濃度	10 μM
	反応時間	16 h
	実験の流れ	501 Mel cell lines are pretreated with each inhibitor (10 μM) or 0.1% DMSO (vehicle) for 16 h. Cycloheximide half-life is examined.

参考

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530153/

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis [ Brazilian Journal of Medical and Biological Research, April 25, 2019, e8412]	PubMed: 31038581
Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer [ Cell Rep Med, 2025, S2666-3791(25)00231-9]	PubMed: 40449480
Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer [ Cell Reports Medicine, 2025, 102158]	PubMed: 40449480
SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism [ BMC Cancer, 2025, 25(1):1304]	PubMed: 40790564
SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism [ BMC Cancer, 2025, 1304]	PubMed: 40790564
SCF-SKP2 E3 ubiquitin ligase links mTORC1/ER stress/ISR with YAP activation in murine renal cystogenesis [ The Journal of Clinical Investigation, 2022-, -Volume 132, Issue 24]	PubMed: None
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST [ British Journal of Cancer, 2022 Sep 29, 2072-2085]
SCF-SKP2 E3 ubiquitin ligase links mTORC1/ER stress/ISR with YAP activation in murine renal cystogenesis [ Journal of Clinical Investigation, 2022 Dec 15, e153943]	PubMed: 36326820
SCF-SKP2 E3 ubiquitin ligase links mTORC1-ER stress-ISR with YAP activation in murine renal cystogenesis [ J Clin Invest, 2022, e153943]	PubMed: 36326820
Nascent transcriptome reveals orchestration of zygotic genome activation in early embryogenesis [ Curr Biol, 2022, 32(19):4314-4324.e7]	PubMed: 36007528

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。